RespireRx Pharmaceuticals (RSPI) 10-Q 2003 Q1 Quarterly report

EXHIBIT 99.1

CERTIFICATION OF PERIODIC REPORT

I, Roger G. Stoll, Ph.D., Chairman, President and Chief Executive Officer of Cortex Pharmaceuticals, Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, that:

(1)	the Quarterly Report on Form 10-Q of the Company for the three months ended March 31, 2003 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 780(d)); and
(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated:      May 15, 2003
	/s/  ROGER G. STOLL, Ph.D.
	Roger G. Stoll, Ph.D. Chairman, President and Chief Executive Officer